- Home
- SVA vs ABLLW Comparison
SVA vs ABLLW Comparison
Compare SVA & ABLLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVA
- ABLLW
- Stock Information
- Founded
- SVA N/A
- ABLLW 2004
- Country
- SVA
- ABLLW United States
- Employees
- SVA 3261
- ABLLW 125
- Industry
- SVA
- ABLLW Investment Managers
- Sector
- SVA
- ABLLW Finance
- Exchange
- SVA NYSE
- ABLLW Nasdaq
- Market Cap
- SVA N/A
- ABLLW N/A
- IPO Year
- SVA N/A
- ABLLW N/A
- Fundamental
- Price
- SVA $6.47
- ABLLW $1.15
- Analyst Decision
- SVA
- ABLLW
- Analyst Count
- SVA 0
- ABLLW 0
- Target Price
- SVA N/A
- ABLLW N/A
- AVG Volume (30 Days)
- SVA N/A
- ABLLW 51.3K
- Earning Date
- SVA N/A
- ABLLW 03-21-2025
- Dividend Yield
- SVA N/A
- ABLLW N/A
- EPS Growth
- SVA N/A
- ABLLW N/A
- EPS
- SVA N/A
- ABLLW N/A
- Revenue
- SVA N/A
- ABLLW $102,407,324.00
- Revenue This Year
- SVA N/A
- ABLLW N/A
- Revenue Next Year
- SVA N/A
- ABLLW N/A
- P/E Ratio
- SVA N/A
- ABLLW N/A
- Revenue Growth
- SVA N/A
- ABLLW 77.68
- 52 Week Low
- SVA N/A
- ABLLW $1.02
- 52 Week High
- SVA N/A
- ABLLW $1.05
- Technical
- Relative Strength Index (RSI)
- SVA N/A
- ABLLW N/A
- Support Level
- SVA N/A
- ABLLW N/A
- Resistance Level
- SVA N/A
- ABLLW N/A
- Average True Range (ATR)
- SVA 0.00
- ABLLW 0.00
- MACD
- SVA 0.00
- ABLLW 0.00
- Stochastic Oscillator
- SVA 0.00
- ABLLW 0.00
About SVA SINOVAC BIOTECH LTD
Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease (HFMD) caused by EV71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps.
About ABLLW Abacus Life Inc.
Abacus Global Management Inc is a financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services. The Company organizes its business into five reportable segments Active Management, Originations, Asset Management, Portfolio Servicing, and Technology Services. Its operations are confined to the United States.